Literature DB >> 8008708

Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites.

T Aoyama1, H Kotaki, Y Sawada, T Iga.   

Abstract

To investigate the stereoselective distribution of methylphenidate (MPD) enantiomers in rats, the concentrations of each enantiomer were determined in plasma and brain regions (cerebellum, striatum, basal forebrain, brain stem, and cortex) after iv administration of racemic MPD and its individual enantiomers. The concentrations of MPD enantiomers in each brain region reached pseudo-steady state within 10 min after iv administration of racemic MPD (2 mg/kg dose). The influx clearances for MPD calculated from Kpapp values in each brain region were not significantly different between MPD enantiomers and between the five brain regions. The mean Kpapp values for (+)-MPD in the striatum at 120 and 240 min after administration of racemic MPD were 10.1 and 10.5, respectively, and these values at each time were significantly larger than the Kpapp values (7.5 and 7.0, respectively) for the (-)-isomer (P < 0.01). The Kpapp value for (+)-MPD in the striatum decreased by coadministration of mazindol as an inhibition of both dopamine and norepinephrine reuptake, but it was not changed by desipramine as a norepinephrine reuptake inhibitor. These results suggest that (+)-MPD was bound specifically to the dopamine reuptake site in the striatum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008708     DOI: 10.1023/a:1018917205292

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.

Authors:  S P Butcher; J Liptrot; G W Aburthnott
Journal:  Neurosci Lett       Date:  1991-01-28       Impact factor: 3.046

2.  Measurement of desipramine in brain tissue by a radioisotope derivative technique.

Authors:  E Riva; P D Hrdina; P L Morselli
Journal:  J Pharm Pharmacol       Date:  1975-10       Impact factor: 3.765

3.  Gas chromatographic-mass spectrometric analysis of threo-methylphenidate enantiomers in plasma.

Authors:  T Aoyama; H Kotaki; Y Saitoh
Journal:  J Chromatogr       Date:  1989-09-29

4.  Conformational similarities between molecular models of phenethylamine and of potent inhibitors of the uptake of tritiated norepinephrine by adrenergic nerves in rabbit aorta.

Authors:  R E Maxwell; E Chaplin; S B Eckhardt; J R Soares; G Hite
Journal:  J Pharmacol Exp Ther       Date:  1970-05       Impact factor: 4.030

5.  Metabolism and disposition of methylphenidate-14C: studies in man and animals.

Authors:  B A Faraj; Z H Israili; J M Perel; M L Jenkins; S G Holtzman; S A Cucinell; P G Dayton
Journal:  J Pharmacol Exp Ther       Date:  1974-12       Impact factor: 4.030

6.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

7.  Autoradiographic localization of [3H]methylphenidate binding sites in rat brain.

Authors:  A S Unis; T M Dawson; D R Gehlert; J K Wamsley
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

8.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

9.  In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.

Authors:  Y L Hurd; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1989-07-18       Impact factor: 4.432

10.  The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake.

Authors:  A Janowsky; M M Schweri; P Berger; R Long; P Skolnick; S M Paul
Journal:  Eur J Pharmacol       Date:  1985-01-22       Impact factor: 4.432

View more
  3 in total

1.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats.

Authors:  T Aoyama; H Kotaki; Y Sawada; T Iga
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  Pharmacodynamic modeling for change of locomotor activity by methylphenidate in rats.

Authors:  T Aoyama; K Yamamoto; H Kotaki; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.